{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:34:39Z","timestamp":1785530079291,"version":"3.56.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,12]]},"DOI":"10.7759\/cureus.43390","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T23:02:52Z","timestamp":1691881372000},"source":"Crossref","is-referenced-by-count":5,"title":["A Conspectus of Euvolemic Hyponatremia, Its Various Etiologies, and Treatment Modalities: A Comprehensive Review of the Literature"],"prefix":"10.7759","author":[{"given":"Anit","family":"Ghosal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza Amna","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravan K","family":"Nekkanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiugo","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.11176","article-title":"Diagnosis and management of hyponatremia: a review","volume":"328","author":"Adrogu\u00e9 HJ","year":"2022","unstructured":"Adrogu\u00e9 HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA. 2022, 328:280-91. 10.1001\/jama.2022.11176","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium--causes, consequences, and correction","volume":"372","author":"Sterns RH","year":"2015","unstructured":"Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med. 2015, 372:55-65. 10.1056\/NEJMra1404489","journal-title":"N Engl J Med"},{"key":"ref3","unstructured":"Hyponatremia. (2023). Accessed. 05\/06\/2023: https:\/\/www.mayoclinic.org\/diseases-conditions\/hyponatremia\/symptoms-causes\/syc-20373711."},{"key":"ref4","article-title":"Diagnostic Evaluation of Adults With Hyponatremia","author":"Sterns RH","year":"2023","unstructured":"Sterns RH. Diagnostic Evaluation of Adults With Hyponatremia. Emmet M, Forman JP (ed): UpToDate, Waltham, MA; 2023."},{"key":"ref5","unstructured":"What is hyponatremia?. (2023). Accessed. 08\/06\/2023: https:\/\/my.clevelandclinic.org\/health\/diseases\/17762-hyponatremia."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(03)00139-0","article-title":"The syndrome of inappropriate antidiuretic hormone secretion","volume":"35","author":"Baylis PH","year":"2003","unstructured":"Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol. 2003, 35:1495-9. 10.1016\/s1357-2725(03)00139-0","journal-title":"Int J Biochem Cell Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000324653","article-title":"The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options","volume":"119","author":"Esposito P","year":"2011","unstructured":"Esposito P, Piotti G, Bianzina S, Malul Y, Dal Canton A. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract. 2011, 119:c62-73; discussion c73. 10.1159\/000324653","journal-title":"Nephron Clin Pract"},{"key":"ref8","article-title":"Disorders of water homeostasis","author":"Srivatsa A","year":"2013","unstructured":"Srivatsa A, Majzoub JA. Disorders of water homeostasis. Pediatric Endocrinology. Lifshitz F (ed): CRC Press, Boca Raton, FL; 2013."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.10.020","article-title":"The syndrome of inappropriate antidiuretic hormone secretion: distribution and characterization according to etiologies","volume":"26","author":"Shepshelovich D","year":"2015","unstructured":"Shepshelovich D, Leibovitch C, Klein A, et al.. The syndrome of inappropriate antidiuretic hormone secretion: distribution and characterization according to etiologies. Eur J Intern Med. 2015, 26:819-24. 10.1016\/j.ejim.2015.10.020","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0463-3","article-title":"SIAD: practical recommendations for diagnosis and management","volume":"39","author":"Cuesta M","year":"2016","unstructured":"Cuesta M, Garrahy A, Thompson CJ. SIAD: practical recommendations for diagnosis and management. J Endocrinol Invest. 2016, 39:991-1001. 10.1007\/s40618-016-0463-3","journal-title":"J Endocrinol Invest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.11.005","article-title":"Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion","volume":"129","author":"Verbalis JG","year":"2016","unstructured":"Verbalis JG, Greenberg A, Burst V, et al.. Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. Am J Med. 2016, 129:537.e9-537.e23. 10.1016\/j.amjmed.2015.11.005","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi SM","year":"2012","unstructured":"Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis. 2012, 59:222-8. 10.1053\/j.ajkd.2011.08.029","journal-title":"Am J Kidney Dis"},{"key":"ref13","article-title":"Characteristics of severe hyponatremia in hospitalized patients; a comparison according to the presence of liver disease","volume":"27","author":"Kim H","year":"2008","unstructured":"Kim H, Lee H, Park HC et al.. Characteristics of severe hyponatremia in hospitalized patients; a comparison according to the presence of liver disease. Korean J of Nephrol. 2008, 27:678-87.","journal-title":"Korean J of Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000493238","article-title":"Euvolemic hyponatremia secondary to the syndrome of inappropriate antidiuresis","volume":"52","author":"Verbalis JG","year":"2019","unstructured":"Verbalis JG. Euvolemic hyponatremia secondary to the syndrome of inappropriate antidiuresis. Front Horm Res. 2019, 52:61-79. 10.1159\/000493238","journal-title":"Front Horm Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088272","article-title":"Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures","volume":"9","author":"Cumming K","year":"2014","unstructured":"Cumming K, Hoyle GE, Hutchison JD, Soiza RL. Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures. PLoS One. 2014, 9:e88272. 10.1371\/journal.pone.0088272","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.4531","article-title":"Tolvaptan treatment in children with chronic hyponatremia due to inappropriate antidiuretic hormone secretion: a report of three cases","volume":"9","author":"Tuli G","year":"2017","unstructured":"Tuli G, Tessaris D, Einaudi S, De Sanctis L, Matarazzo P. Tolvaptan treatment in children with chronic hyponatremia due to inappropriate antidiuretic hormone secretion: a report of three cases. J Clin Res Pediatr Endocrinol. 2017, 9:288-92. 10.4274\/jcrpe.4531","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.03.010","article-title":"Hyponatremia in cancer patients: time for a new approach","volume":"102","author":"Berardi R","year":"2016","unstructured":"Berardi R, Rinaldi S, Caramanti M, et al.. Hyponatremia in cancer patients: time for a new approach. Crit Rev Oncol Hematol. 2016, 102:15-25. 10.1016\/j.critrevonc.2016.03.010","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5152\/balkanmedj.2013.9424","article-title":"Codeine-induced syndrome of inappropriate antidiuretic hormone: case report","volume":"31","author":"Karahan S","year":"2014","unstructured":"Karahan S, Karag\u00f6z H, Erden A, Avc\u0131 D, Esmeray K. Codeine-induced syndrome of inappropriate antidiuretic hormone: case report. Balkan Med J. 2014, 31:107-9. 10.5152\/balkanmedj.2013.9424","journal-title":"Balkan Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0400","article-title":"Diagnosis and management of hyponatremia in cancer patients","volume":"17","author":"Castillo JJ","year":"2012","unstructured":"Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012, 17:756-65. 10.1634\/theoncologist.2011-0400","journal-title":"Oncologist"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21780","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone in patients with brucellosis","volume":"29","author":"Dulger AC","year":"2015","unstructured":"Dulger AC, Aslan M, Ceylan MR, Olmez S, Karadas S, Akdeniz H. The syndrome of inappropriate secretion of antidiuretic hormone in patients with brucellosis. J Clin Lab Anal. 2015, 29:366-9. 10.1002\/jcla.21780","journal-title":"J Clin Lab Anal"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.3.512","article-title":"Pneumonia and the syndrome of inappropriate antidiuretic hormone secretion: don't pour water on the fire","volume":"138","author":"Dixon BS","year":"1988","unstructured":"Dixon BS, Anderson RJ. Pneumonia and the syndrome of inappropriate antidiuretic hormone secretion: don't pour water on the fire. Am Rev Respir Dis. 1988, 138:512-3. 10.1164\/ajrccm\/138.3.512","journal-title":"Am Rev Respir Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0500","article-title":"Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia","volume":"10","author":"Kumar A","year":"2021","unstructured":"Kumar A, Ghosh M, Jacob JJ. Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia. Endocr Connect. 2021, 10:1623-31. 10.1530\/EC-21-0500","journal-title":"Endocr Connect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/315059a0","article-title":"Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy","volume":"315","author":"Wolfson B","year":"1985","unstructured":"Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino F Jr. Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature. 1985, 315:59-61. 10.1038\/315059a0","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12465","article-title":"The diagnosis and management of inpatient hyponatraemia and SIADH","volume":"45","author":"Grant P","year":"2015","unstructured":"Grant P, Ayuk J, Bouloux PM, et al.. The diagnosis and management of inpatient hyponatraemia and SIADH. Eur J Clin Invest. 2015, 45:888-94. 10.1111\/eci.12465","journal-title":"Eur J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-15-5-553","article-title":"Hypophysectomy in man: effect on water excretion during the first two postoperative months","volume":"15","author":"IK D","year":"1955","unstructured":"IK D, LU R, OL H. Hypophysectomy in man: effect on water excretion during the first two postoperative months. J Clin Endocrinol Metab. 1955, 15:553-67. 10.1210\/jcem-15-5-553","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1199","article-title":"Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?","volume":"184","author":"Laugesen K","year":"2021","unstructured":"Laugesen K, Broersen LH, Hansen SB, Dekkers OM, S\u00f8rensen HT, Jorgensen JO. Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?. Eur J Endocrinol. 2021, 184:R111-22. 10.1530\/EJE-20-1199","journal-title":"Eur J Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351607","article-title":"Adrenal insufficiency","volume":"335","author":"Oelkers W","year":"1996","unstructured":"Oelkers W. Adrenal insufficiency. N Engl J Med. 1996, 335:1206-12. 10.1056\/NEJM199610173351607","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0300-2977(01)00081-x","article-title":"Hyponatremia due to hypothyroidism: a pure renal mechanism","volume":"58","author":"Schmitz PH","year":"2001","unstructured":"Schmitz PH, de Meijer PH, Meinders AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth J Med. 2001, 58:143-9. 10.1016\/s0300-2977(01)00081-x","journal-title":"Neth J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-27","article-title":"Acute severe hypothyroidism is not associated with hyponatremia even with increased water intake: a prospective study in thyroid cancer patients","volume":"13","author":"Hammami MM","year":"2013","unstructured":"Hammami MM, Almogbel F, Hammami S, Faifi J, Alqahtani A, Hashem W. Acute severe hypothyroidism is not associated with hyponatremia even with increased water intake: a prospective study in thyroid cancer patients. BMC Endocr Disord. 2013, 13:27. 10.1186\/1472-6823-13-27","journal-title":"BMC Endocr Disord"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0493","article-title":"Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment","volume":"176","author":"Liamis G","year":"2017","unstructured":"Liamis G, Filippatos TD, Liontos A, Elisaf MS. Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment. Eur J Endocrinol. 2017, 176:R15-20. 10.1530\/EJE-16-0493","journal-title":"Eur J Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106390","article-title":"On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and mineralocorticoids in reversing the inhibition","volume":"49","author":"Green HH","year":"1970","unstructured":"Green HH, Harrington AR, Valtin H. On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and mineralocorticoids in reversing the inhibition. J Clin Invest. 1970, 49:1724-36. 10.1172\/JCI106390","journal-title":"J Clin Invest"},{"key":"ref32","article-title":"Myxedematous coma with hypervasopressinism. Two observations [Article in French]","volume":"138","author":"Archambeaud-Mouveroux F","year":"1987","unstructured":"Archambeaud-Mouveroux F, Dejax C, Jadaud JM, Vincent D, Laroumagne G , Hessel L , Laubie B. Myxedematous coma with hypervasopressinism. Two observations [Article in French]. Ann Intern Med. 1987, 138:114-8.","journal-title":"Ann Intern Med"},{"key":"ref33","article-title":"The controversies of hyponatraemia in hypothyroidism: weighing the evidence","volume":"15","author":"Abuzaid AS","year":"2015","unstructured":"Abuzaid AS, Birch N. The controversies of hyponatraemia in hypothyroidism: weighing the evidence. Sultan Qaboos Univ Med J. 2015, 15:e207-12.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.02.064","article-title":"Electrolyte disorders associated with the use of anticancer drugs","volume":"777","author":"Liamis G","year":"2016","unstructured":"Liamis G, Filippatos TD, Elisaf MS. Electrolyte disorders associated with the use of anticancer drugs. Eur J Pharmacol. 2016, 777:78-87. 10.1016\/j.ejphar.2016.02.064","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0025-7","article-title":"Psychogenic polydipsia review: etiology, differential, and treatment","volume":"9","author":"Dundas B","year":"2007","unstructured":"Dundas B, Harris M, Narasimhan M. Psychogenic polydipsia review: etiology, differential, and treatment. Curr Psychiatry Rep. 2007, 9:236-41. 10.1007\/s11920-007-0025-7","journal-title":"Curr Psychiatry Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02103.x","article-title":"Diagnosis and management of hyponatraemia in hospitalised patients","volume":"63","author":"Reddy P","year":"2009","unstructured":"Reddy P, Mooradian AD. Diagnosis and management of hyponatraemia in hospitalised patients. Int J Clin Pract. 2009, 63:1494-508. 10.1111\/j.1742-1241.2009.02103.x","journal-title":"Int J Clin Pract"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin","volume":"102","author":"Anderson RJ","year":"1985","unstructured":"Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985, 102:164-8. 10.7326\/0003-4819-102-2-164","journal-title":"Ann Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197603000-00002","article-title":"Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes","volume":"55","author":"Arieff AI","year":"1976","unstructured":"Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore). 1976, 55:121-9. 10.1097\/00005792-197603000-00002","journal-title":"Medicine (Baltimore)"},{"key":"ref39","article-title":"The charted and the uncharted waters of hyponatremia","volume":"21","author":"Gross PA","year":"1987","unstructured":"Gross PA, Ketteler M, Hausmann C, Ritz E. The charted and the uncharted waters of hyponatremia. Kidney Int Suppl. 1987, 21:S67-75.","journal-title":"Kidney Int Suppl"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: a class-by-class review of literature","volume":"55","author":"De Picker L","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014, 55:536-47. 10.1016\/j.psym.2014.01.010","journal-title":"Psychosomatics"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4525-9","article-title":"Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study","volume":"234","author":"Yang HJ","year":"2017","unstructured":"Yang HJ, Cheng WJ. Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study. Psychopharmacology (Berl). 2017, 234:869-76. 10.1007\/s00213-017-4525-9","journal-title":"Psychopharmacology (Berl)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02930.x","article-title":"Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review","volume":"35","author":"Van Amelsvoort T","year":"1994","unstructured":"Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994, 35:181-8. 10.1111\/j.1528-1157.1994.tb02930.x","journal-title":"Epilepsia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G209","article-title":"Carbamazepine-induced hyponatremia: assessment of risk factors","volume":"39","author":"Kuz GM","year":"2005","unstructured":"Kuz GM, Manssourian A. Carbamazepine-induced hyponatremia: assessment of risk factors. Ann Pharmacother. 2005, 39:1943-6. 10.1345\/aph.1G209","journal-title":"Ann Pharmacother"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/15622970600960157","article-title":"Hyponatremia-induced seizure during carbamazepine treatment","volume":"8","author":"Holtschmidt-T\u00e4schner B","year":"2007","unstructured":"Holtschmidt-T\u00e4schner B, Soyka M. Hyponatremia-induced seizure during carbamazepine treatment. World J Biol Psychiatry. 2007, 8:51-3. 10.1080\/15622970600960157","journal-title":"World J Biol Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/BF01788840","article-title":"Hyponatremia related to medical anticancer treatment","volume":"4","author":"Berghmans T","year":"1996","unstructured":"Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer. 1996, 4:341-50. 10.1007\/BF01788840","journal-title":"Support Care Cancer"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.1992.7.2.118","article-title":"Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer","volume":"7","author":"Lee YK","year":"1992","unstructured":"Lee YK, Shin DM. Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer. Korean J Intern Med. 1992, 7:118-21. 10.3904\/kjim.1992.7.2.118","journal-title":"Korean J Intern Med"},{"key":"ref47","article-title":"Hyponatremia induced by angiotensin converting enzyme inhibitors and angiotensin receptor blockers-a pilot study","volume":"12","author":"Bhuvaneshwari S","year":"20181","unstructured":"Bhuvaneshwari S, Saroj PV, Vijaya D, Sowmya MS, Kumar RS. Hyponatremia induced by angiotensin converting enzyme inhibitors and angiotensin receptor blockers-a pilot study. J Clin Diagn Res. 20181, 12:1-3.","journal-title":"J Clin Diagn Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.07.012","article-title":"Incidence of hyponatremia with high-dose trimethoprim-sulfamethoxazole exposure","volume":"129","author":"Tsapepas D","year":"2016","unstructured":"Tsapepas D, Chiles M, Babayev R, Rao MK, Jaitly M, Salerno D, Mohan S. Incidence of hyponatremia with high-dose trimethoprim-sulfamethoxazole exposure. Am J Med. 2016, 129:1322-8. 10.1016\/j.amjmed.2016.07.012","journal-title":"Am J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4598(199709)20:9<1102::aid-mus2>3.0.co;2-c","article-title":"Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases","volume":"20","author":"Koffman BM","year":"1997","unstructured":"Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve. 1997, 20:1102-7. 10.1002\/(sici)1097-4598(199709)20:9&lt;1102::aid-mus2&gt;3.0.co;2-c","journal-title":"Muscle Nerve"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1159\/000104424","article-title":"Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy","volume":"106","author":"Daphnis E","year":"2007","unstructured":"Daphnis E, Stylianou K, Alexandrakis M, Xylouri I, Vardaki E, Stratigis S, Kyriazis J. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract. 2007, 106:c143-8. 10.1159\/000104424","journal-title":"Nephron Clin Pract"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A review of drug-induced hyponatremia","volume":"52","author":"Liamis G","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008, 52:144-53. 10.1053\/j.ajkd.2008.03.004","journal-title":"Am J Kidney Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-82-1-61_1","article-title":"Water intoxication and thioridazine (Mellaril)","volume":"82","author":"Rao KJ","year":"1975","unstructured":"Rao KJ, Miller M, Moses A. Water intoxication and thioridazine (Mellaril). Ann Intern Med. 1975, 82:61. 10.7326\/0003-4819-82-1-61_1","journal-title":"Ann Intern Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211030270","article-title":"Analysis of the frequency and onset time of hyponatremia\/syndrome of inappropriate antidiuretic hormone induced by antidepressants or antipsychotics","volume":"56","author":"Takeda K","year":"2022","unstructured":"Takeda K, Kobayashi C, Nakai T, Oishi T, Okada A. Analysis of the frequency and onset time of hyponatremia\/syndrome of inappropriate antidiuretic hormone induced by antidepressants or antipsychotics. Ann Pharmacother. 2022, 56:303-8. 10.1177\/10600280211030270","journal-title":"Ann Pharmacother"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.797039","article-title":"The role of vasopressin V2 receptor in drug-induced hyponatremia","volume":"12","author":"Kim S","year":"2021","unstructured":"Kim S, Jo CH, Kim GH. The role of vasopressin V2 receptor in drug-induced hyponatremia. Front Physiol. 2021, 12:797039. 10.3389\/fphys.2021.797039","journal-title":"Front Physiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.5301\/jn.5000074","article-title":"Normal fractional urate excretion identifies hyponatremic patients with reset osmostat","volume":"25","author":"Imbriano LJ","year":"2012","unstructured":"Imbriano LJ, Ilamathi E, Ali NM, Miyawaki N, Maesaka JK. Normal fractional urate excretion identifies hyponatremic patients with reset osmostat. J Nephrol. 2012, 25:833-8. 10.5301\/jn.5000074","journal-title":"J Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050284","article-title":"A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis","volume":"8","author":"Berghmans T","year":"2000","unstructured":"Berghmans T, Paesmans M, Body JJ. A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer. 2000, 8:192-7. 10.1007\/s005200050284","journal-title":"Support Care Cancer"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.05.015","article-title":"The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period","volume":"68","author":"Hansen O","year":"2010","unstructured":"Hansen O, S\u00f8rensen P, Hansen KH. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer. 2010, 68:111-4. 10.1016\/j.lungcan.2009.05.015","journal-title":"Lung Cancer"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2683-z","article-title":"Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients","volume":"23","author":"Berardi R","year":"2015","unstructured":"Berardi R, Caramanti M, Castagnani M, et al.. Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support Care Cancer. 2015, 23:3095-101. 10.1007\/s00520-015-2683-z","journal-title":"Support Care Cancer"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3905","article-title":"Difficult-to-treat syndrome of inappropriate antidiuretic hormone secretion in a patient with secondary central nervous system lymphoma","volume":"11","author":"Joshi H","year":"2019","unstructured":"Joshi H, Nagumantry S, Pierres F, Oyibo SO, Sagi SV. Difficult-to-treat syndrome of inappropriate antidiuretic hormone secretion in a patient with secondary central nervous system lymphoma. Cureus. 2019, 11:e3905. 10.7759\/cureus.3905","journal-title":"Cureus"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13966","article-title":"Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence","volume":"90","author":"Nervo A","year":"2019","unstructured":"Nervo A, D'Angelo V, Rosso D, Castellana E, Cattel F, Arvat E, Grossi E. Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence. Clin Endocrinol (Oxf). 2019, 90:842-8. 10.1111\/cen.13966","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e3181e63682","article-title":"Cisplatin-induced renal salt wasting syndrome","volume":"103","author":"Hamdi T","year":"2010","unstructured":"Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A. Cisplatin-induced renal salt wasting syndrome. South Med J. 2010, 103:793-9. 10.1097\/SMJ.0b013e3181e63682","journal-title":"South Med J"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.07.021","article-title":"Prevalence of hyponatremia and association with mortality: results from NHANES","volume":"126","author":"Mohan S","year":"2013","unstructured":"Mohan S, Gu S, Parikh A, Radhakrishnan J. Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med. 2013, 126:1127-37.e1. 10.1016\/j.amjmed.2013.07.021","journal-title":"Am J Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2013.08.010","article-title":"Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study","volume":"76","author":"Mannesse CK","year":"2013","unstructured":"Mannesse CK, Jansen PA, Van Marum RJ, Sival RC, Kok RM, Haffmans PM, Egberts TC. Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study. Maturitas. 2013, 76:357-63. 10.1016\/j.maturitas.2013.08.010","journal-title":"Maturitas"},{"key":"ref64","article-title":"Hyponatremia in hospitalized older adults is associated with polypharmacy, longer hospital stay, and higher mortality","volume":"12","author":"Auriemma L","year":"2018","unstructured":"Auriemma L, Quarto GV, Fracalossi GA, Buzatto BC, Felix TP, Tieppo A, Morelato RL. Hyponatremia in hospitalized older adults is associated with polypharmacy, longer hospital stay, and higher mortality. Geriatr Gerontol. Aging. 2018, 12:202-5.","journal-title":"Geriatr Gerontol. Aging"},{"key":"ref65","article-title":"Endocrine Testing for the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)","author":"Pliquett RU","year":"2022","unstructured":"Pliquett RU, Oberm\u00fcller N. Endocrine Testing for the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Feingold KR, Anawalt B, Blackman MR et al. (ed): Endotext [Internet], South Dartmouth, MA; 2022."},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509096102","article-title":"Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances","volume":"102","author":"Noakes TD","year":"2005","unstructured":"Noakes TD, Sharwood K, Speedy D, et al.. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci U S A. 2005, 102:18550-5. 10.1073\/pnas.0509096102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2019.11.003","article-title":"Wilderness Medical Society clinical practice guidelines for the management of exercise-associated hyponatremia: 2019 update","volume":"31","author":"Bennett BL","year":"2020","unstructured":"Bennett BL, Hew-Butler T, Rosner MH, Myers T, Lipman GS. Wilderness Medical Society clinical practice guidelines for the management of exercise-associated hyponatremia: 2019 update. Wilderness Environ Med. 2020, 31:50-62. 10.1016\/j.wem.2019.11.003","journal-title":"Wilderness Environ Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1097\/JSM.0000000000000221","article-title":"Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015","volume":"25","author":"Hew-Butler T","year":"2015","unstructured":"Hew-Butler T, Rosner MH, Fowkes-Godek S, et al.. Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clin J Sport Med. 2015, 25:303-20. 10.1097\/JSM.0000000000000221","journal-title":"Clin J Sport Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1097\/00042752-200411000-00004","article-title":"Study of hematological and biochemical parameters in runners completing a standard marathon","volume":"14","author":"Reid SA","year":"2004","unstructured":"Reid SA, Speedy DB, Thompson JM, et al.. Study of hematological and biochemical parameters in runners completing a standard marathon. Clin J Sport Med. 2004, 14:344-53. 10.1097\/00042752-200411000-00004","journal-title":"Clin J Sport Med"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02730806","article-title":"Exercise-associated hyponatremia","volume":"2","author":"Rosner MH","year":"2007","unstructured":"Rosner MH, Kirven J. Exercise-associated hyponatremia. Clin J Am Soc Nephrol. 2007, 2:151-61. 10.2215\/CJN.02730806","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222916","article-title":"Considering exercise-associated hyponatraemia as a continuum","volume":"2018","author":"Lewis D","year":"2018","unstructured":"Lewis D, Blow A, Tye J, Hew-Butler T. Considering exercise-associated hyponatraemia as a continuum. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-222916","journal-title":"BMJ Case Rep"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsams.2013.09.001","article-title":"Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia","volume":"17","author":"Owen BE","year":"2014","unstructured":"Owen BE, Rogers IR, Hoffman MD, et al.. Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia. J Sci Med Sport. 2014, 17:457-62. 10.1016\/j.jsams.2013.09.001","journal-title":"J Sci Med Sport"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3810\/psm.2009.04.1693","article-title":"Case report: exercise-associated hyponatremia with rhabdomyolysis during endurance exercise","volume":"37","author":"Ellis C","year":"2009","unstructured":"Ellis C, Cuthill J, Hew-Butler T, George SM, Rosner MH. Case report: exercise-associated hyponatremia with rhabdomyolysis during endurance exercise. Phys Sportsmed. 2009, 37:126-32. 10.3810\/psm.2009.04.1693","journal-title":"Phys Sportsmed"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2010.06.012","article-title":"Rhabdomyolysis and hyponatremia: a cluster of five cases at the 161-km 2009 Western States Endurance Run","volume":"21","author":"Bruso JR","year":"2010","unstructured":"Bruso JR, Hoffman MD, Rogers IR, Lee L, Towle G, Hew-Butler T. Rhabdomyolysis and hyponatremia: a cluster of five cases at the 161-km 2009 Western States Endurance Run. Wilderness Environ Med. 2010, 21:303-8. 10.1016\/j.wem.2010.06.012","journal-title":"Wilderness Environ Med"},{"key":"ref75","article-title":"Overview of Postoperative Electrolyte Abnormalities","author":"Siparsky N","year":"2023","unstructured":"Siparsky N. Overview of Postoperative Electrolyte Abnormalities. Cochran A, Sterns RH, Collins KA (ed): UpToDate, Waltham, MA; 2023."},{"key":"ref76","article-title":"Les hyponatr\u00e9mies postop\u00e9ratoires de l\u2019enfant : physiopathologie, diagnostic et traitement. Postoperative hyponatremia in children: pathophysiology, diagnosis and treatment [Article in French]","volume":"23","author":"Brouh Y","year":"20041","unstructured":"Brouh Y, Paut O, Tsimaratos M, Camboulives J. Les hyponatr\u00e9mies postop\u00e9ratoires de l\u2019enfant : physiopathologie, diagnostic et traitement. Postoperative hyponatremia in children: pathophysiology, diagnosis and treatment [Article in French]. Ann Fr Anesth Reanim. 20041, 23:39-49.","journal-title":"Ann Fr Anesth Reanim"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0776-x","article-title":"Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)","volume":"41","author":"Sbardella E","year":"2018","unstructured":"Sbardella E, Isidori AM, Arnaldi G, et al.. Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest. 2018, 41:3-19. 10.1007\/s40618-017-0776-x","journal-title":"J Endocrinol Invest"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90209-8","article-title":"Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis","volume":"78","author":"Ayus JC","year":"1985","unstructured":"Ayus JC, Krothapalli RK, Arieff AI. Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Am J Med. 1985, 78:897-902. 10.1016\/0002-9343(85)90209-8","journal-title":"Am J Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V481522","article-title":"Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective","volume":"4","author":"Sterns RH","year":"1994","unstructured":"Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994, 4:1522-30. 10.1681\/ASN.V481522","journal-title":"J Am Soc Nephrol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02939.x","article-title":"Hyponatremia and risk of seizures: a retrospective cross-sectional study","volume":"52","author":"Halawa I","year":"2011","unstructured":"Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia. 2011, 52:410-3. 10.1111\/j.1528-1167.2010.02939.x","journal-title":"Epilepsia"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.241401","article-title":"Evaluation of NT-ProBNP as a marker of the volume status of neurosurgical patients developing hyponatremia and natriuresis: a pilot study","volume":"66","author":"Tobin G","year":"2018","unstructured":"Tobin G, Chacko AG, Simon R. Evaluation of NT-ProBNP as a marker of the volume status of neurosurgical patients developing hyponatremia and natriuresis: a pilot study. Neurol India. 2018, 66:1383-8. 10.4103\/0028-3886.241401","journal-title":"Neurol India"},{"key":"ref82","article-title":"Nt-proBNP: a new test for diagnosis, prognosis and management of congestive heart failure","volume":"1","author":"Sakhuja R","year":"2004","unstructured":"Sakhuja R, Januzzi J. Nt-proBNP: a new test for diagnosis, prognosis and management of congestive heart failure. US Cardiology. 2004, 1:1-5.","journal-title":"US Cardiology"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3171\/2008.9.JNS08191","article-title":"Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study","volume":"111","author":"Kristof RA","year":"2009","unstructured":"Kristof RA, Rother M, Neuloh G, Klingm\u00fcller D. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. 2009, 111:555-62. 10.3171\/2008.9.JNS08191","journal-title":"J Neurosurg"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3171\/2013.7.JNS13273","article-title":"Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations","volume":"119","author":"Jahangiri A","year":"2013","unstructured":"Jahangiri A, Wagner J, Tran MT, et al.. Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations. J Neurosurg. 2013, 119:1478-83. 10.3171\/2013.7.JNS13273","journal-title":"J Neurosurg"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1159\/000094725","article-title":"Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors","volume":"83","author":"Sata A","year":"2006","unstructured":"Sata A, Hizuka N, Kawamata T, Hori T, Takano K. Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors. Neuroendocrinology. 2006, 83:117-22. 10.1159\/000094725","journal-title":"Neuroendocrinology"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2007.106.1.66","article-title":"Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery","volume":"106","author":"Zada G","year":"2007","unstructured":"Zada G, Liu CY, Fishback D, Singer PA, Weiss MH. Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg. 2007, 106:66-71. 10.3171\/jns.2007.106.1.66","journal-title":"J Neurosurg"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2019.05.011","article-title":"Sodium perturbations after pituitary surgery","volume":"30","author":"Yuen KC","year":"2019","unstructured":"Yuen KC, Ajmal A, Correa R, Little AS. Sodium perturbations after pituitary surgery. Neurosurg Clin N Am. 2019, 30:515-24. 10.1016\/j.nec.2019.05.011","journal-title":"Neurosurg Clin N Am"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.689887","article-title":"Tolvaptan in the management of acute euvolemic hyponatremia after transsphenoidal surgery: a retrospective single-center analysis","volume":"12","author":"Indirli R","year":"2021","unstructured":"Indirli R, Ferreira de Carvalho J, Cremaschi A, et al.. Tolvaptan in the management of acute euvolemic hyponatremia after transsphenoidal surgery: a retrospective single-center analysis. Front Endocrinol (Lausanne). 2021, 12:689887. 10.3389\/fendo.2021.689887","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2017.15.2.42","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) associated with mediastinal schwannoma","volume":"15","author":"Song SH","year":"2017","unstructured":"Song SH, Sim GA, Baek SH, Seo JW, Shim JW, Koo JR. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) associated with mediastinal schwannoma. Electrolyte Blood Press. 2017, 15:42-6. 10.5049\/EBP.2017.15.2.42","journal-title":"Electrolyte Blood Press"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-023-04472-5","article-title":"Tolvaptan for treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) in a child with corpus callosum agenesis","author":"Meena AK","year":"2023","unstructured":"Meena AK, Nanda PM, Sharma R, Chakrabarty B, Gulati S. Tolvaptan for treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) in a child with corpus callosum agenesis. Indian J Pediatr. 2023, 10.1007\/s12098-023-04472-5","journal-title":"Indian J Pediatr"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.02.003","article-title":"Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia","volume":"30","author":"Christ-Crain M","year":"2016","unstructured":"Christ-Crain M, Morgenthaler NG, Fenske W. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Best Pract Res Clin Endocrinol Metab. 2016, 30:235-47. 10.1016\/j.beem.2016.02.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2021.102167","article-title":"Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction","volume":"89","author":"S\u0103c\u0103rescu A","year":"2021","unstructured":"S\u0103c\u0103rescu A, Turliuc MD, Br\u0103ni\u0219teanu DD. Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction. Neuropeptides. 2021, 89:102167. 10.1016\/j.npep.2021.102167","journal-title":"Neuropeptides"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.08.019","article-title":"Use of conivaptan for management of hyponatremia following surgery for Cushing's disease","volume":"115","author":"Breshears JD","year":"2013","unstructured":"Breshears JD, Jiang B, Rowland NC, Kunwar S, Blevins LS. Use of conivaptan for management of hyponatremia following surgery for Cushing's disease. Clin Neurol Neurosurg. 2013, 115:2358-61. 10.1016\/j.clineuro.2013.08.019","journal-title":"Clin Neurol Neurosurg"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31817b8148","article-title":"Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"337","author":"Annane D","year":"2009","unstructured":"Annane D, Decaux G, Smith N. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci. 2009, 337:28-36. 10.1097\/MAJ.0b013e31817b8148","journal-title":"Am J Med Sci"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.12659\/msm.899977","article-title":"The syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and brucellosis","volume":"22","author":"Bala KA","year":"2016","unstructured":"Bala KA, Do\u011fan M, Kaba S, et al.. The syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and brucellosis. Med Sci Monit. 2016, 22:3129-34. 10.12659\/msm.899977","journal-title":"Med Sci Monit"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2012.06.001","article-title":"Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan","volume":"28","author":"Friedman B","year":"2013","unstructured":"Friedman B, Cirulli J. Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan. J Crit Care. 2013, 28:219.e1-12. 10.1016\/j.jcrc.2012.06.001","journal-title":"J Crit Care"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1159\/000078883","article-title":"Dysnatremias in the critical care setting","volume":"144","author":"Moritz ML","year":"2004","unstructured":"Moritz ML, Ayus JC. Dysnatremias in the critical care setting. Contrib Nephrol. 2004, 144:132-57. 10.1159\/000078883","journal-title":"Contrib Nephrol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2006.09.011","article-title":"Disorders of body water homeostasis in critical illness","volume":"35","author":"Adler SM","year":"2006","unstructured":"Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am. 2006, 35:873-94, xi. 10.1016\/j.ecl.2006.09.011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp040300","article-title":"Treatment of electrolyte disorders in adult patients in the intensive care unit","volume":"62","author":"Kraft MD","year":"2005","unstructured":"Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005, 62:1663-82. 10.2146\/ajhp040300","journal-title":"Am J Health Syst Pharm"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181dda0be","article-title":"Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit","volume":"38","author":"Buckley MS","year":"2010","unstructured":"Buckley MS, Leblanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med. 2010, 38:S253-64. 10.1097\/CCM.0b013e3181dda0be","journal-title":"Crit Care Med"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-351x(05)80300-3","article-title":"The syndrome of acquired glucocorticoid resistance in HIV infection","volume":"8","author":"Norbiato G","year":"1994","unstructured":"Norbiato G, Galli M, Righini V, Moroni M. The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin Endocrinol Metab. 1994, 8:777-87. 10.1016\/s0950-351x(05)80300-3","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.155","article-title":"Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience","volume":"33","author":"Park GH","year":"2018","unstructured":"Park GH, Lee CM, Song JW, et al.. Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience. Korean J Intern Med. 2018, 33:561-7. 10.3904\/kjim.2016.155","journal-title":"Korean J Intern Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis JG","year":"2007","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007, 120:S1-21. 10.1016\/j.amjmed.2007.09.001","journal-title":"Am J Med"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.93734","article-title":"Vasopressin receptor antagonists and their role in clinical medicine","volume":"16","author":"Narayen G","year":"2012","unstructured":"Narayen G, Mandal SN. Vasopressin receptor antagonists and their role in clinical medicine. Indian J Endocrinol Metab. 2012, 16:183-91. 10.4103\/2230-8210.93734","journal-title":"Indian J Endocrinol Metab"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14036","article-title":"Nonosmotic secretion of arginine vasopressin and salt loss in hyponatremia in Kawasaki disease","volume":"62","author":"Miura K","year":"2020","unstructured":"Miura K, Harita Y, Takahashi N, et al.. Nonosmotic secretion of arginine vasopressin and salt loss in hyponatremia in Kawasaki disease. Pediatr Int. 2020, 62:363-70. 10.1111\/ped.14036","journal-title":"Pediatr Int"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmac025","article-title":"Macroprolactinoma-induced syndrome of inappropriate antidiuresis and its reversal with dopamine agonist therapy","volume":"53","author":"Schlegel A","year":"2022","unstructured":"Schlegel A. Macroprolactinoma-induced syndrome of inappropriate antidiuresis and its reversal with dopamine agonist therapy. Lab Med. 2022, 53:537-9. 10.1093\/labmed\/lmac025","journal-title":"Lab Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2021.2021.0191","article-title":"Nephrogenic syndrome of inappropriate antidiuresis mimicking hyporeninemic hypoaldosteronism: case report of two infants","volume":"15","author":"Mammadova J","year":"2023","unstructured":"Mammadova J, Kara C, \u00c7elebi Bitkin E, \u0130zci G\u00fcll\u00fc E, Ayd\u0131n M. Nephrogenic syndrome of inappropriate antidiuresis mimicking hyporeninemic hypoaldosteronism: case report of two infants. J Clin Res Pediatr Endocrinol. 2023, 15:214-9. 10.4274\/jcrpe.galenos.2021.2021.0191","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9920817","article-title":"Tolvaptan response in a hyponatremic newborn with syndrome of inappropriate secretion of antidiuretic hormone","volume":"2021","author":"Zeybek C","year":"2021","unstructured":"Zeybek C, Bozat AD, Calisici E, Bolat A, Saygili Karagol B. Tolvaptan response in a hyponatremic newborn with syndrome of inappropriate secretion of antidiuretic hormone. Case Rep Pediatr. 2021, 2021:9920817. 10.1155\/2021\/9920817","journal-title":"Case Rep Pediatr"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06690-8","article-title":"The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report","volume":"21","author":"Lindner G","year":"2021","unstructured":"Lindner G, Ryser B. The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report. BMC Infect Dis. 2021, 21:1000. 10.1186\/s12879-021-06690-8","journal-title":"BMC Infect Dis"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2021.1979738","article-title":"Asymptomatic hyponatremia precipitated by COVID-19 pneumonia","volume":"11","author":"Chittal AR","year":"2021","unstructured":"Chittal AR, Rao SJ, Lakra P, Zulty ME. Asymptomatic hyponatremia precipitated by COVID-19 pneumonia. J Community Hosp Intern Med Perspect. 2021, 11:779-81. 10.1080\/20009666.2021.1979738","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211045249","article-title":"Hyponatremia and fever in a patient on ipilimumab and nivolumab (immune checkpoint inhibitors): a case report","volume":"9","author":"Patel SS","year":"2021","unstructured":"Patel SS, Roy S, Pokal M, Gayam V, Adapa S, Patel ES. Hyponatremia and fever in a patient on ipilimumab and nivolumab (immune checkpoint inhibitors): a case report. J Investig Med High Impact Case Rep. 2021, 9:23247096211045249. 10.1177\/23247096211045249","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.684131","article-title":"Case report: long-term tolvaptan treatment in a child with SIADH and suprasellar arachnoid cyst","volume":"9","author":"Puma A","year":"2021","unstructured":"Puma A, Brugnara M, Cavarzere P, Zaffanello M, Piacentini G, Gaudino R. Case report: long-term tolvaptan treatment in a child with SIADH and suprasellar arachnoid cyst. Front Pediatr. 2021, 9:684131. 10.3389\/fped.2021.684131","journal-title":"Front Pediatr"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2020.101290","article-title":"COVID-19 presented with syndrome of inappropriate ADH secretion(SIADH): a case report from Bangladesh","volume":"31","author":"Uddin Chowdhury MR","year":"2020","unstructured":"Uddin Chowdhury MR, Akter KS, Moula MM, Kabir MA, Bhuiyan SI, Das BC. COVID-19 presented with syndrome of inappropriate ADH secretion(SIADH): a case report from Bangladesh. Respir Med Case Rep. 2020, 31:101290. 10.1016\/j.rmcr.2020.101290","journal-title":"Respir Med Case Rep"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235558","article-title":"Trimethoprim-induced hyponatremia mimicking SIADH in a patient with pulmonary nocardiosis: use of point-of-care ultrasound in apparent euvolemic hypotonic hyponatremia","volume":"13","author":"Saha BK","year":"2020","unstructured":"Saha BK, Chong WH. Trimethoprim-induced hyponatremia mimicking SIADH in a patient with pulmonary nocardiosis: use of point-of-care ultrasound in apparent euvolemic hypotonic hyponatremia. BMJ Case Rep. 2020, 13:e235558. 10.1136\/bcr-2020-235558","journal-title":"BMJ Case Rep"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2020.11.026","article-title":"Development of inappropriate vasopressin secretion in association with lumbar cerebrospinal fluid drainage in an adult with traumatic basilar skull fracture","volume":"7","author":"Rhyu J","year":"2021","unstructured":"Rhyu J, Yu R. Development of inappropriate vasopressin secretion in association with lumbar cerebrospinal fluid drainage in an adult with traumatic basilar skull fracture. AACE Clin Case Rep. 2021, 7:124-6. 10.1016\/j.aace.2020.11.026","journal-title":"AACE Clin Case Rep"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02423-8","article-title":"Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report","volume":"14","author":"van der Zalm IJ","year":"2020","unstructured":"van der Zalm IJ, Tob\u00e9 TJ, Logtenberg SJ. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. J Med Case Rep. 2020, 14:83. 10.1186\/s13256-020-02423-8","journal-title":"J Med Case Rep"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12681","article-title":"A case of severe hyponatremia due to linezolid-induced SIADH","volume":"43","author":"Ioannou P","year":"2018","unstructured":"Ioannou P, Stavroulaki M, Mavrikaki V, Papakitsou I, Panagiotakis S. A case of severe hyponatremia due to linezolid-induced SIADH. J Clin Pharm Ther. 2018, 43:434-6. 10.1111\/jcpt.12681","journal-title":"J Clin Pharm Ther"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0729-y","article-title":"Paraneoplastic syndrome as the presentation of limited stage small cell carcinoma","volume":"18","author":"Nikoomanesh K","year":"2018","unstructured":"Nikoomanesh K, Choi J, Arabian S. Paraneoplastic syndrome as the presentation of limited stage small cell carcinoma. BMC Pulm Med. 2018, 18:169. 10.1186\/s12890-018-0729-y","journal-title":"BMC Pulm Med"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.12890\/2017_000594","article-title":"Three synchronous tumors discovered in SIADH investigation","volume":"4","author":"Fonseca R","year":"2017","unstructured":"Fonseca R, Monteiro F, Mendes R. Three synchronous tumors discovered in SIADH investigation. Eur J Case Rep Intern Med. 2017, 4:000594. 10.12890\/2017_000594","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1159\/000466697","article-title":"Hypertrophic pachymeningitis and the syndrome of inappropriate antidiuretic hormone secretion: coincidence or cause?","volume":"26","author":"Harsch IA","year":"2017","unstructured":"Harsch IA, Schiffer A, Konturek PC. Hypertrophic pachymeningitis and the syndrome of inappropriate antidiuretic hormone secretion: coincidence or cause?. Med Princ Pract. 2017, 26:289-91. 10.1159\/000466697","journal-title":"Med Princ Pract"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2016.14.2.31","article-title":"A case report of syndrome of inappropriate antidiuretic hormone induced by pregabalin","volume":"14","author":"Jung YJ","year":"2016","unstructured":"Jung YJ, Lee DY, Kim HW, Park HS, Kim B. A case report of syndrome of inappropriate antidiuretic hormone induced by pregabalin. Electrolyte Blood Press. 2016, 14:31-4. 10.5049\/EBP.2016.14.2.31","journal-title":"Electrolyte Blood Press"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3186714","article-title":"SIADH induced by pharyngeal squamous cell carcinoma: case report and literature review","volume":"2016","author":"Arshad HM","year":"2016","unstructured":"Arshad HM, Rodriguez A, Suhail F. SIADH induced by pharyngeal squamous cell carcinoma: case report and literature review. Case Rep Nephrol. 2016, 2016:3186714. 10.1155\/2016\/3186714","journal-title":"Case Rep Nephrol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.29902","article-title":"Hyponatremia as the initial presentation of cryptococcal meningitis after liver transplantation","volume":"15","author":"Mansoor S","year":"2015","unstructured":"Mansoor S, Juhardeen H, Alnajjar A, et al.. Hyponatremia as the initial presentation of cryptococcal meningitis after liver transplantation. Hepat Mon. 2015, 15:e29902. 10.5812\/hepatmon.29902","journal-title":"Hepat Mon"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1159\/000350910","article-title":"Hyponatremia - a rare but serious complication of amiodarone: a case report and review of the literature","volume":"3","author":"Pham L","year":"2013","unstructured":"Pham L, Shaer AJ, Marnejon T. Hyponatremia - a rare but serious complication of amiodarone: a case report and review of the literature. Case Rep Nephrol Urol. 2013, 3:46-50. 10.1159\/000350910","journal-title":"Case Rep Nephrol Urol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2016-0165","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone and hyponatremia","volume":"39","author":"Jones DP","year":"2018","unstructured":"Jones DP. Syndrome of inappropriate secretion of antidiuretic hormone and hyponatremia. Pediatr Rev. 2018, 39:27-35. 10.1542\/pir.2016-0165","journal-title":"Pediatr Rev"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.911810","article-title":"Chronic hyponatremia due to the syndrome of inappropriate antidiuresis (SIAD) in an adult woman with corpus callosum agenesis (CCA)","volume":"19","author":"Silveira MA","year":"2018","unstructured":"Silveira MA, Seguro AC, da Silva JB, et al.. Chronic hyponatremia due to the syndrome of inappropriate antidiuresis (SIAD) in an adult woman with corpus callosum agenesis (CCA). Am J Case Rep. 2018, 19:1345-9. 10.12659\/AJCR.911810","journal-title":"Am J Case Rep"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: compilation of the guidelines","volume":"28","author":"Hoorn EJ","year":"2017","unstructured":"Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017, 28:1340-9. 10.1681\/ASN.2016101139","journal-title":"J Am Soc Nephrol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04431007","article-title":"Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone","volume":"3","author":"Decaux G","year":"2008","unstructured":"Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008, 3:1175-84. 10.2215\/CJN.04431007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1063","article-title":"The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences","volume":"162 Suppl 1","author":"Hannon MJ","year":"2010","unstructured":"Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010, 162 Suppl 1:S5-12. 10.1530\/EJE-09-1063","journal-title":"Eur J Endocrinol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison DH","year":"2007","unstructured":"Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007, 356:2064-72. 10.1056\/NEJMcp066837","journal-title":"N Engl J Med"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S95326","article-title":"Dose comparison of conivaptan (Vaprisol\u00ae) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics","volume":"10","author":"Palmer BF","year":"2016","unstructured":"Palmer BF, Rock AD, Woodward EJ. Dose comparison of conivaptan (Vaprisol\u00ae) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics. Drug Des Devel Ther. 2016, 10:339-51. 10.2147\/DDDT.S95326","journal-title":"Drug Des Devel Ther"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2007.762","article-title":"Tumor-related hyponatremia","volume":"5","author":"Onitilo AA","year":"2007","unstructured":"Onitilo AA, Kio E, Doi SA. Tumor-related hyponatremia. Clin Med Res. 2007, 5:228-37. 10.3121\/cmr.2007.762","journal-title":"Clin Med Res"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00033.2004","article-title":"Downward resetting of the osmotic threshold for thirst in patients with SIADH","volume":"287","author":"Smith D","year":"2004","unstructured":"Smith D, Moore K, Tormey W, Baylis PH, Thompson CJ. Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab. 2004, 287:E1019-23. 10.1152\/ajpendo.00033.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200004000-00007","article-title":"The urine\/plasma electrolyte ratio: a predictive guide to water restriction","volume":"319","author":"Furst H","year":"2000","unstructured":"Furst H, Hallows KR, Post J, et al.. The urine\/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci. 2000, 319:240-4. 10.1097\/00000441-200004000-00007","journal-title":"Am J Med Sci"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03149.x","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study","volume":"69","author":"Verbalis JG","year":"2008","unstructured":"Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf). 2008, 69:159-68. 10.1111\/j.1365-2265.2007.03149.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier RW","year":"2006","unstructured":"Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006, 355:2099-112. 10.1056\/NEJMoa065181","journal-title":"N Engl J Med"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.11.032","article-title":"Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia","volume":"61","author":"Sood L","year":"2013","unstructured":"Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013, 61:571-8. 10.1053\/j.ajkd.2012.11.032","journal-title":"Am J Kidney Dis"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.12.024","article-title":"A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion","volume":"55","author":"Berl T","year":"2010","unstructured":"Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis. 2010, 55:742-8. 10.1053\/j.ajkd.2009.12.024","journal-title":"Am J Kidney Dis"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e32833bfa64","article-title":"Treatment of hyponatremia","volume":"19","author":"Sterns RH","year":"2010","unstructured":"Sterns RH, Hix JK, Silver S. Treatment of hyponatremia. Curr Opin Nephrol Hypertens. 2010, 19:493-8. 10.1097\/MNH.0b013e32833bfa64","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14265","article-title":"Treatment of severe symptomatic hyponatremia","volume":"7","author":"Tandukar S","year":"2019","unstructured":"Tandukar S, Rondon-Berrios H. Treatment of severe symptomatic hyponatremia. Physiol Rep. 2019, 7:e14265. 10.14814\/phy2.14265","journal-title":"Physiol Rep"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.04.005","article-title":"Hyponatraemia--SIADH in lung cancer diagnostic and treatment algorithms","volume":"96","author":"Groh\u00e9 C","year":"2015","unstructured":"Groh\u00e9 C, Berardi R, Burst V. Hyponatraemia--SIADH in lung cancer diagnostic and treatment algorithms. Crit Rev Oncol Hematol. 2015, 96:1-8. 10.1016\/j.critrevonc.2015.04.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.3390\/jcm3031043","article-title":"Actual therapeutic indication of an old drug: urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH","volume":"3","author":"Decaux G","year":"2014","unstructured":"Decaux G, Gankam Kengne F, Couturier B, Vandergheynst F, Musch W, Soupart A. Actual therapeutic indication of an old drug: urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH. J Clin Med. 2014, 3:1043-9. 10.3390\/jcm3031043","journal-title":"J Clin Med"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft113","article-title":"Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases","volume":"6","author":"Laville M","year":"2013","unstructured":"Laville M, Burst V, Peri A, Verbalis JG. Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases. Clin Kidney J. 2013, 6:i1-i20. 10.1093\/ckj\/sft113","journal-title":"Clin Kidney J"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.5301\/jo-n.5000025","article-title":"Risk of serum sodium overcorrection with V2 antagonists in SIADH and other high risk patients","volume":"1","author":"Kamgar M","year":"2017","unstructured":"Kamgar M, Hanna RM, Hasnain H, Khalil D, Wilson JM. Risk of serum sodium overcorrection with V2 antagonists in SIADH and other high risk patients. J Onco Nephrol. 2017, 1:143-6. 10.5301\/jo-n.5000025","journal-title":"J Onco Nephrol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2019.09.004","article-title":"Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan","volume":"2","author":"Hanna RM","year":"2020","unstructured":"Hanna RM, Velez JC, Rastogi A, et al.. Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan. Kidney Med. 2020, 2:20-8. 10.1016\/j.xkme.2019.09.004","journal-title":"Kidney Med"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e32830e45e3","article-title":"Diagnosis and management of hyponatremia in acute illness","volume":"14","author":"Schrier RW","year":"2008","unstructured":"Schrier RW, Bansal S. Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care. 2008, 14:627-34. 10.1097\/MCC.0b013e32830e45e3","journal-title":"Curr Opin Crit Care"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28468","article-title":"Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety","volume":"120","author":"Salahudeen AK","year":"2014","unstructured":"Salahudeen AK, Ali N, George M, Lahoti A, Palla S. Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer. 2014, 120:744-51. 10.1002\/cncr.28468","journal-title":"Cancer"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis JG","year":"2011","unstructured":"Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol. 2011, 164:725-32. 10.1530\/EJE-10-1078","journal-title":"Eur J Endocrinol"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346668","article-title":"Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"33","author":"Peri A","year":"2010","unstructured":"Peri A, Pirozzi N, Parenti G, Festuccia F, Men\u00e8 P. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Invest. 2010, 33:671-82. 10.1007\/BF03346668","journal-title":"J Endocrinol Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/176544-a-conspectus-of-euvolemic-hyponatremia-its-various-etiologies-and-treatment-modalities-a-comprehensive-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:29Z","timestamp":1707509069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/176544-a-conspectus-of-euvolemic-hyponatremia-its-various-etiologies-and-treatment-modalities-a-comprehensive-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":149,"URL":"https:\/\/doi.org\/10.7759\/cureus.43390","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,12]]}}}